The purpose of this study is to determine clinical efficacy and safety of INCB018424, a small molecule Janus kinase (JAK) inhibitor, in patients with refractory or relapsed multiple myeloma.

Official Title

A Phase 2, Two Stage, Open-Label, Clinical Trial to Determine the Therapeutic Effect and Safety of an Oral JAK2-Inhibitor (INCB018424) in Patients With Relapsed or Refractory Multiple Myeloma.

Conditions

  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Multiple Myeloma

Study Type

Interventional

Study Design

Treatment, Randomised, Open Label, Single Group Assignment, Safety/Efficacy Study.

Further Details

Primary Outcome Measures:

  • Safety and tolerability of patients and response rates will be assessed using International Uniform Response Criteria (IRC) for multiple myeloma for all patients treated with study medication.
    [Time Frame: End Of Study]
    [Designated as safety issue: No]

Secondary Outcome Measures:

  • To study preliminary effectiveness of oral INCB018424 alone or in combination with dexamethasone in a patient population diagnosed with multiple myeloma.
    [Time Frame: End of study]
    [Designated as safety issue: No]

Study Start

March 2008 -September 2008

Eligibility & Criteria

  • Ages Eligible for Study: 

     

       18 Years and older

  •  

        Genders Eligible for Study:

     

       Both  

Inclusion Criteria:

  • Confirmed diagnosis of multiple myeloma with evidence of measurable disease.
  • Relapsed or refractory disease with at least one line of prior therapy.
  • Adequate bone marrow reserve.

Exclusion Criteria:

  • Received anti-cancer medications or investigational therapy in the past 28 days.
  • Intracranial disease or epidural disease.

Total Enrolment

37

Contact Details

Sara Malhotra (PhD)
Phone No: + 302-498-6830
Email: smalhotra@incyte.com

Location:

 

 Highland, California
USA, 9234

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.